Last update :
28/04/2024
Anticancer drug   Nelarabine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Arranon United States of America
Atriance Belgium, Canada, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland
Stability in solutions   Injection   Stability in solutions : Nelarabine     
Container Solvent Concentration Temperature Storage Duration of stability References
Ethylene vinyl acetate None 5 mg/ml 2-8°C Protect from light
28 Day
3225
Level of evidence A

Ethylene vinyl acetate None 5 mg/ml 20-25°C With or without light
28 Day
3225
Level of evidence A


  Mentions Légales